Evaluating Ischemia-Modified Albumin as an Early Biomarker for Hypertensive Disorders During Pregnancy: A Case-Control Study

Background Ischemia-modified albumin (IMA) is looked upon as a newer marker of myocardial ischemia. There is a paucity of literature however with regard to studies correlating levels of IMA in patients with hypertensive disorders of pregnancy. The present study therefore aimed at estimating the leve...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Jyoti E, Sakarde, Apurva, Misra, Swayam Swaroop, Mundle, Shuchita, Jose, Jancy, Tripathi, Satyendra Chandra, Amle, Dnyanesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706492/
https://www.ncbi.nlm.nih.gov/pubmed/36457615
http://dx.doi.org/10.7759/cureus.30867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706492/
https://www.ncbi.nlm.nih.gov/pubmed/36457615
http://dx.doi.org/10.7759/cureus.30867

Ejemplares similares